Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hallucinatory delirium following use of MDPV: "Bath Salts".

× No keyword cloud information.

17 in total

1. Death following recreational use of designer drug "bath salts" containing 3,4-Methylenedioxypyrovalerone (MDPV).

Authors: Brittany L Murray; Christine M Murphy; Michael C Beuhler
Journal: J Med Toxicol Date: 2012-03

2. "Bath salts"-induced psychosis in a young woman.

Authors: Sadaf Khan; Farhat Shaheen; Hina Sarwar; Jules Molina; Saira Mushtaq
Journal: Prim Care Companion CNS Disord Date: 2013

Review 3. Synthetic cathinones ("bath salts").

Authors: Matthew L Banks; Travis J Worst; Daniel E Rusyniak; Jon E Sprague
Journal: J Emerg Med Date: 2014-02-22 Impact factor: 1.484

4. Atypical dopamine efflux caused by 3,4-methylenedioxypyrovalerone (MDPV) via the human dopamine transporter.

Authors: Aparna Shekar; Jenny I Aguilar; Greta Galli; Nicholas V Cozzi; Simon D Brandt; Arnold E Ruoho; Michael H Baumann; Heinrich J G Matthies; Aurelio Galli
Journal: J Chem Neuroanat Date: 2017-02-03 Impact factor: 3.052

Review 5. A case of fatal idiosyncratic reaction to the designer drug 3,4-methylenedioxypyrovalerone (MDPV) and review of the literature.

Authors: Brigitte Desharnais; Yann Dazé; Laura M Huppertz; Pascal Mireault; Cameron D Skinner
Journal: Forensic Sci Med Pathol Date: 2017-07-01 Impact factor: 2.007

6. The Psychoactive Designer Drug and Bath Salt Constituent MDPV Causes Widespread Disruption of Brain Functional Connectivity.

Authors: Luis M Colon-Perez; Kelvin Tran; Khalil Thompson; Michael C Pace; Kenneth Blum; Bruce A Goldberger; Mark S Gold; Adriaan W Bruijnzeel; Barry Setlow; Marcelo Febo
Journal: Neuropsychopharmacology Date: 2016-03-21 Impact factor: 7.853

7. Sensitization to the motor stimulant effects of 3,4-methylenedioxypyrovalerone (MDPV) and cross-sensitization to methamphetamine in rats.

Authors: Lucas R Watterson; Peter R Kufahl; Sara B Taylor; Natali E Nemirovsky; M Foster Olive
Journal: J Drug Alcohol Res Date: 2016-05

8. Role of hypocretin/orexin receptor blockade on drug-taking and ultrasonic vocalizations (USVs) associated with low-effort self-administration of cathinone-derived 3,4-methylenedioxypyrovalerone (MDPV) in rats.

Authors: Steven J Simmons; Rose Martorana; Helene Philogene-Khalid; Fionya H Tran; Taylor A Gentile; Xinyan Xu; Shu Su; Scott M Rawls; John W Muschamp
Journal: Psychopharmacology (Berl) Date: 2017-08-07 Impact factor: 4.530

9. Binge-like acquisition of α-pyrrolidinopentiophenone (α-PVP) self-administration in female rats.

Authors: Mehrak Javadi-Paydar; Eric L Harvey; Yanabel Grant; Sophia A Vandewater; Kevin M Creehan; Jacques D Nguyen; Tobin J Dickerson; Michael A Taffe
Journal: Psychopharmacology (Berl) Date: 2018-06-16 Impact factor: 4.530

10. The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats.

Authors: S M Aarde; P K Huang; K M Creehan; T J Dickerson; M A Taffe
Journal: Neuropharmacology Date: 2013-04-15 Impact factor: 5.250